Investing.com — CME Group’s attempt to fast-track a round-the-clock mini oil futures contract has hit a regulatory wall, with the U.S. Commodity Futures Trading Commission preparing to block the filing before it can take effect, according to Financial Times.
CME Group Inc () shares are trading 2.1% lower on Thursday morning after the report emerged, as its push to capture retail demand for after-hours commodity trading now faces a potentially lengthy detour through the formal review process.
Weigh 24/7 trading by upgrading to InvestingPro – get 60% off today
Financial Times reported that CME filed on Wednesday to self-certify the new product, a designed to trade around the clock, giving the CFTC just one day to intervene before the contract could list. A person familiar with the matter told Financial Times that the regulator plans to block the self-certification, citing concern that swift approval would immediately open the door to larger round-the-clock offerings that could strain market infrastructure during hours when energy markets have historically been closed.
CME had announced the contract in June, framing it as a response to investor demand to manage positions “whenever news breaks,” particularly as dramatic price swings tied to U.S.-Iran tensions drew a surge of retail participation into oil markets. The exchange described the self-certification route as its typical approach for a “smaller” version of an existing product, but noted it had also filed a parallel application through the lengthier regulatory channel at the CFTC’s request, according to Financial Times. That second application, subject to a 45-day review process, remains under active consideration by the regulator.
The CFTC’s resistance appears rooted in structural concern rather than opposition to the product concept outright. Financial Times noted that CFTC Chair Michael Selig has met in recent weeks with senior executives from Shell, Vitol, BP and ExxonMobil as part of the agency’s review, a consultation sweep suggesting the regulator is taking the views of the largest physical market participants before blessing any expansion of trading hours for .
The standoff is the latest friction point in a deteriorating relationship between CME and its primary regulator. Financial Times reported that CME last month filed a lawsuit against the CFTC over the agency’s approval of so-called perpetual crypto derivatives, contracts that allow traders to bet on digital asset prices without the expiration mechanics of traditional futures. That legal action signals that CME views the regulatory environment as selectively permissive toward newer, crypto-adjacent trading venues while constraining its own product development.
WTI crude has been a focal point for volatility in recent months, with geopolitical risk premiums creating the kind of price gyrations that retail traders and smaller institutional participants cite when demanding continuous access to hedging tools. CME’s commercial logic for the 10-barrel contract is straightforward: smaller notional size lowers the barrier to entry for retail participants, and 24/7 availability means positions can be adjusted in response to overnight developments without waiting for the pit to reopen. The CFTC’s concern is that approving even a small-notional contract through the expedited process would effectively set a precedent that makes it harder to refuse the larger-volume version that would inevitably follow.
From an equity standpoint, the block represents a near-term headwind to CME’s growth narrative around retail engagement and exchange-hour expansion. Futures and options revenue is the core driver of CME’s top line, and management had signaled appetite for broadening the retail oil franchise as part of a wider strategy to compete with the always-on nature of crypto derivatives platforms. The 45-day formal review process means a resolution, in either direction, is unlikely before late summer at the earliest, keeping uncertainty over this product line elevated through the back half of the trading year.
Investors will be watching whether CME escalates its legal posture toward the CFTC or opts to work cooperatively through the standard review channel. The outcome of the 45-day application will be the critical next catalyst, as an approval would validate CME’s strategy and could re-rate its retail derivatives growth prospects, while a rejection would intensify pressure on management to articulate an alternative path to capturing after-hours commodity trading demand.